MX2011009709A - Compuestos para el tratamiento de la inflamacion y del dolor. - Google Patents

Compuestos para el tratamiento de la inflamacion y del dolor.

Info

Publication number
MX2011009709A
MX2011009709A MX2011009709A MX2011009709A MX2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A
Authority
MX
Mexico
Prior art keywords
pain
methylsulfonyl
treating inflammation
butyric acid
present
Prior art date
Application number
MX2011009709A
Other languages
English (en)
Spanish (es)
Inventor
Joseph P St Laurent
Original Assignee
Olatec Ind Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olatec Ind Llc filed Critical Olatec Ind Llc
Publication of MX2011009709A publication Critical patent/MX2011009709A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2011009709A 2009-03-18 2010-03-16 Compuestos para el tratamiento de la inflamacion y del dolor. MX2011009709A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16128509P 2009-03-18 2009-03-18
PCT/US2010/027501 WO2010107807A2 (en) 2009-03-18 2010-03-16 Compounds for treating inflammation and pain

Publications (1)

Publication Number Publication Date
MX2011009709A true MX2011009709A (es) 2011-12-06

Family

ID=42738194

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009709A MX2011009709A (es) 2009-03-18 2010-03-16 Compuestos para el tratamiento de la inflamacion y del dolor.

Country Status (11)

Country Link
US (1) US7851650B2 (cg-RX-API-DMAC7.html)
EP (1) EP2408740B1 (cg-RX-API-DMAC7.html)
JP (1) JP5587969B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110128348A (cg-RX-API-DMAC7.html)
CN (1) CN102438983A (cg-RX-API-DMAC7.html)
AU (1) AU2010226794A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1014528A2 (cg-RX-API-DMAC7.html)
CA (1) CA2755678A1 (cg-RX-API-DMAC7.html)
MX (1) MX2011009709A (cg-RX-API-DMAC7.html)
RU (1) RU2520034C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010107807A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG182621A1 (en) * 2010-02-04 2012-08-30 Novabay Pharmaceuticals Inc Polysaccharide based antimicrobial formulations
MX2013006708A (es) * 2010-12-15 2013-09-13 Olatec Ind Llc Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor.
KR102002664B1 (ko) 2012-02-27 2019-07-23 오라텍 세라퓨틱스 엘엘씨 3-메틸술포닐프로피오니트릴의 제조 방법
AU2013271778B2 (en) * 2012-06-05 2018-03-01 Olatec Therapeutics Llc Pharmaceutical composition for treating inflammation and pain
US9481644B2 (en) 2012-06-05 2016-11-01 Olatec Therapeutics Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
JP6185575B2 (ja) 2012-06-05 2017-08-23 オラテック セラピューティクス リミティド ライアビリティ カンパニー 皮膚炎症性疾患の治療方法
CA2875053C (en) * 2012-06-05 2020-07-14 Olatec Industries Llc Pharmaceutical composition for treating inflammation and pain
MX368641B (es) 2012-06-11 2019-10-09 Olatec Ind Llc Compuestos para el tratamiento de inflamación y dolor.
WO2013188314A1 (en) * 2012-06-14 2013-12-19 Olatec Industries Llc Compounds for treating inflammation and pain
US9114122B2 (en) 2012-06-14 2015-08-25 Olatec Industries Llc Compounds for treating inflammation and pain
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
WO2015081188A1 (en) * 2013-11-27 2015-06-04 Olatec Industries Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
WO2025097064A1 (en) * 2023-11-03 2025-05-08 Mencanin Steve Novel ampoule for delivery of polymers for wound treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3700729A1 (de) * 1987-01-13 1988-07-21 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JP2930723B2 (ja) * 1992-11-19 1999-08-03 アンティキャンサー インコーポレーテド 抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用
PY970104A (es) 1996-08-30 2001-12-03 Monsanto Co Nuevos fluidos solubles en agua para trabajar metales
US6638701B1 (en) * 2002-12-17 2003-10-28 Eastman Kodak Company Photographic element containing a red dye-forming pyrazolotriazole coupler
RU2232752C1 (ru) * 2003-04-04 2004-07-20 Общество с ограниченной ответственностью "Поливит" Способ получения фосфата или сукцината 2-амино-4-метилтио-(s-оксо-s-имино)-масляной кислоты
US7423064B2 (en) 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
JPWO2006118196A1 (ja) * 2005-04-27 2008-12-18 味の素株式会社 Dpp4阻害剤及びその医薬用途
DE602006018367D1 (de) * 2006-03-20 2010-12-30 Olatec Ind Llc Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen
EP2111252A4 (en) * 2007-01-31 2010-12-01 Adam Heller MANAGEMENT OF PAIN BY ELECTROCHEMICAL PATHWAY

Also Published As

Publication number Publication date
CA2755678A1 (en) 2010-09-23
WO2010107807A3 (en) 2011-01-13
EP2408740A2 (en) 2012-01-25
RU2520034C2 (ru) 2014-06-20
WO2010107807A2 (en) 2010-09-23
KR20110128348A (ko) 2011-11-29
EP2408740A4 (en) 2012-08-08
US7851650B2 (en) 2010-12-14
JP5587969B2 (ja) 2014-09-10
BRPI1014528A2 (pt) 2016-04-05
US20100240756A1 (en) 2010-09-23
AU2010226794A1 (en) 2011-10-27
JP2012520888A (ja) 2012-09-10
EP2408740B1 (en) 2013-11-20
RU2011142008A (ru) 2013-04-27
CN102438983A (zh) 2012-05-02

Similar Documents

Publication Publication Date Title
WO2010107807A3 (en) Compounds for treating inflammation and pain
WO2012082718A3 (en) 3-methanesulfonylpropionitrile for treating inflammation and pain
MX2013012588A (es) Inhibidores de cinasa.
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
EA201270570A1 (ru) Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90
MX338554B (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
MX2011011083A (es) Compuestos heterociclicos como inhibidores de mek.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
PH12014500065A1 (en) A new therapeutical composition containing apomorphine as active ingredient
WO2012050831A3 (en) Combination treatment for dermatological conditions
EA201490864A1 (ru) Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов
MX2013003638A (es) Tratamiento en combinacion para rosacea.
PH12012501552A1 (en) Therapeutic or prophylactic agent for biliary diseases
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
IN2013DN02555A (cg-RX-API-DMAC7.html)
WO2010022201A3 (en) Folinic acid derivatives for promoting bone growth
RU2015112121A (ru) Ми-рнк и их применение в способах и композициях для лечения и/или профилактики глазных состояний
WO2010002835A3 (en) Vinpocetine and eburnamonine derivatives for promoting bone growth
IN2014KN01113A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
FG Grant or registration